Skip to main content
Top
Published in: Reactions Weekly 1/2017

01-12-2017 | Case report

Cytarabine/idarubicin

Septic shock: case report

Published in: Reactions Weekly | Issue 1/2017

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference He J, et al. Novel homobarringtonie-containing therapy for the treatment of patients with primary acute myeloid leukemia that are resistant to conventional therapy. Oncology Letters 14: 7597-7607, No. 6, Dec 2017. Available from: URL: http://doi.org/10.3892/ol.2017.7084 - China He J, et al. Novel homobarringtonie-containing therapy for the treatment of patients with primary acute myeloid leukemia that are resistant to conventional therapy. Oncology Letters 14: 7597-7607, No. 6, Dec 2017. Available from: URL: http://​doi.​org/​10.​3892/​ol.​2017.​7084 - China
Metadata
Title
Cytarabine/idarubicin
Septic shock: case report
Publication date
01-12-2017
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-39398-9

Other articles of this Issue 1/2017

Reactions Weekly 1/2017 Go to the issue

Case report

Magnesium/plasma

Case report

Tocilizumab